News-Medical.Net on MSN
A slow-growing, bone-covered, noncancerous mass named as ossifying spindled and epithelioid tumor
It's not often that a pathologist gets to make a diagnosis that works for the patient by preventing treatment from occurring.
Investigator-Initiated Preclinical studies at CIC biomaGUNE aimed at combatting Glioblastoma Multiforme Research will ...
Dr. Reddy’s receives exclusive rights to develop and commercialise Eftilagimod Alfa in all countries outside North America, ...
According to the agreement, Immutep will receive from Dr Reddy's an upfront payment of $20 million (around AUD 30.2 million) ...
Efti is Immutep's first-in-class novel immunotherapy that directly activates the immune system to fight cancer.
Sydney-based Immutep and Dr Reddy’s Laboratories have inked an exclusive licensing agreement through their arms for the ...
A late-stage immunotherapy company targeting cancer and autoimmune diseases, Immutep holds global manufacturing rights to the product across all markets. It will supply the product to Dr. Reddy’s in ...
Allison Patterson, a member of the Pasto family, needs help this holiday season, so owners Michael and Shaylee Bartalone are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback